Tun Lin

Internal Medicine
9024 Corona Ave
Elmhurst, NY 11373

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Journal: Cancer research
Published: April 28, 2025
Showing 1-1 of 1

Last Updated: 09/26/2026